Literature DB >> 2453372

Growth response of human myeloid leukemia cells to colony-stimulating factors.

M J Pébusque1, M Lopez, H Torres, A Carotti, L Guilbert, P Mannoni.   

Abstract

The effects of human recombinant granulocyte and granulocyte-macrophage- (G- and GM-CSF), and of purified macrophage-stimulating factors (CSF-1), were tested on populations of leukemia cells isolated from 18 patients with different types of acute myeloid leukemia. Cell proliferation and differentiation were studied by culturing the cells in suspension for 7 days in the presence of CSF or medium alone. Spontaneous cell proliferation, as assessed by tritiated thymidine uptake, was observed in 9 of the 18 cases. GM-CSF induced proliferation in seven of the nine cases without spontaneous growth and increased spontaneous proliferation in nine cases. G-CSF added alone was also found to strongly stimulate leukemic blast cell proliferation, in which a translocation involving the long arm of chromosome 17 was observed. Low levels of CSF-1 stimulation were also observed in some cases. No clear morphological modification supporting evidence of terminal differentiation was observed, whereas modulation of some cell surface antigens was detected by flow cytometry. Thus, most leukemia cells still depend on growth factors for their proliferation, GM-CSF appearing the most effective. On the other hand these factors were not able to induce terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453372

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  9 in total

Review 1.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

2.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Recombinant human colony stimulating factor-granulocyte/macrophage and -granulocyte, but not macrophage induce the development of a respiratory burst in primary human myeloid leukemic cells in vitro.

Authors:  K Geissler; G Tricot; G Grimm; P Siostrzonek; H Broxmeyer
Journal:  Blut       Date:  1989-09

Review 4.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

5.  Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction.

Authors:  S F Ziegler; T A Bird; K K Morella; B Mosley; D P Gearing; H Baumann
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

6.  Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains.

Authors:  A Larsen; T Davis; B M Curtis; S Gimpel; J E Sims; D Cosman; L Park; E Sorensen; C J March; C A Smith
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

7.  Recombinant Human Granulocyte Colony-Stimulating Factor Promotes Preinvasive and Invasive Estrogen Receptor-Positive Tumor Development in MMTV-erbB2 Mice.

Authors:  Chun Ling Zhao; Guang Ping Zhang; Zheng Zheng Xiao; Zhi Kun Ma; Cai Peng Lei; Shi Yuan Song; Ying Ying Feng; Ya Chao Zhao; Xiao Shan Feng
Journal:  J Breast Cancer       Date:  2015-06-26       Impact factor: 3.588

Review 8.  The importance of the granulocyte-colony stimulating factor in oncology.

Authors:  Sînziana Cetean; Călin Căinap; Anne-Marie Constantin; Simona Căinap; Alexandra Gherman; Luminiţa Oprean; Adriana Hangan; Radu Oprean
Journal:  Clujul Med       Date:  2015-11-15

Review 9.  The significance of aminopeptidases and haematopoietic cell differentiation.

Authors:  K Razak; A C Newland
Journal:  Blood Rev       Date:  1992-12       Impact factor: 8.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.